What Can Simulate Nature? Aid Blockbuster Drugs? And Get Congress to Agree? - USC Viterbi School of Engineering

USC researchers demonstrated a quantum simulator capable of modeling complex molecular interactions, potentially accelerating drug discovery by simulating nature at atomic scales with unprecedented precision. The breakthrough leverages trapped-ion quantum processors, achieving error-corrected simulations of protein folding—key for designing blockbuster pharmaceuticals like cancer therapies and antiviral drugs. Congressional bipartisan support emerged after a USC-led briefing showcased quantum’s role in national security and healthcare, securing preliminary funding for a $200M quantum-biology research initiative. Industry partnerships with Pfizer and Moderna are already testing the simulator to optimize drug candidates, cutting R&D timelines by up to 40% in early trials. The team aims to scale the system to 1,000+ qubits by 2027, targeting FDA-approved quantum-aided drug designs within five years, marking a shift from classical to quantum-driven pharmaceutical innovation.